Home »
1997 Issues »
62 FR (07/21/1997) » 97-19012. Merck & Co., Inc., et al.; Withdrawal of Approval of 39 New Drug Applications, 13 Abbreviated Antibiotic Applications, and 46 Abbreviated New Drug Applications; Correction
97-19012. Merck & Co., Inc., et al.; Withdrawal of Approval of 39 New Drug Applications, 13 Abbreviated Antibiotic Applications, and 46 Abbreviated New Drug Applications; Correction
[Federal Register Volume 62, Number 139 (Monday, July 21, 1997)]
[Notices]
[Page 39003]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-19012]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 87N-0262]
Merck & Co., Inc., et al.; Withdrawal of Approval of 39 New Drug
Applications, 13 Abbreviated Antibiotic Applications, and 46
Abbreviated New Drug Applications; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a notice
that appeared in the Federal Register of June 25, 1997 (62 FR 34297).
The document announced the withdrawal of approval of 39 new drug
applications (NDA's), 13 abbreviated antibiotic applications (AADA's),
and 46 abbreviated new drug applications (ANDA's). The document
inadvertently withdrew approval of NDA 50-678 for DYNABAC
(dirithromycin tablets) held by Lilly Research Laboratories, Lilly
Corporate Center, Indianapolis, IN 46285. This document confirms that
approval of NDA 50-678 is still in effect, and that the withdrawal of
approval of the NDA was in error.
EFFECTIVE DATE: June 25, 1997.
FOR FURTHER INFORMATION CONTACT: Olivia A. Vieira, Center for Drug
Evaluation and Research (HFD-7), Food and Drug Administration, 1451
Rockville Pike, Rockville, MD 20852, 301-594-2041.
In FR Doc. 97-16609 appearing on page 34297 in the issue of
Wednesday, June 25, 1997, the following correction is made: On page
34298, in the table, the entry for NDA 50-678 is removed.
Dated: July 11, 1997.
Janet Woodcock,
Director, Center for Drug Evaluation and Research.
[FR Doc. 97-19012 Filed 7-18-97; 8:45 am]
BILLING CODE 4160-01-F
Document Information
- Effective Date:
- 6/25/1997
- Published:
- 07/21/1997
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice; correction.
- Document Number:
- 97-19012
- Dates:
- June 25, 1997.
- Pages:
- 39003-39003 (1 pages)
- Docket Numbers:
- Docket No. 87N-0262
- PDF File:
-
97-19012.pdf